Panav Biotech’s RIFAXIN (Rifaximin 400 mg) is a gut-selective, non-absorbable antibiotic, targeting bacterial gastrointestinal (GI) infections in dogs, cattle, and horses.
INDICATIONS
- Bacterial GI Infections: Treatment of acute bacterial diarrhea, gastroenteritis, colitis, and enterocolitis.
- Chronic Enteropathy in Dogs: Used as an alternative to metronidazole for managing chronic intestinal diseases.
- Hepatic Encephalopathy (General Vet Use): Used to reduce ammonia-producing bacteria in the gut.
- Bacterial Diarrhoea (General Vet Use): Used in the treatment of traveler’s diarrhea-like symptoms and infections caused by non-enteroinvasive E. coli.
ADMINISTRATION
- Method of Delivery: It is administered orally, typically in bolus or tablet form.
- Timing: It can generally be given with or without food.
- Dosage: Specific dosages are determined based on the animal’s weight and the condition.
- Target Species: Commonly prescribed for dogs and cats for bacterial GI infections and chronic enteropathy.
Specific Formulations & Uses
- Intestinal Therapy: RIFAXIN is marketed by Panav Biotech specifically for targeted intestinal action in animals.
- Livestock Use: Rifaximin in cattle may be administered via intramammary or intrauterine routes for specific conditions like mastitis or metritis
